Drugline is a fortnightly electronic drug bulletin for health professionals.
Scroll

Drugline

Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

Glucagon-like Peptide-1 Analogues

Drugline Volume 346

Dulaglutide (Trulicity®) is a new glucagon-like peptide-1 (GLP-1) analogue available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of type 2 diabetes. GLP-1 is an intestinally-derived incretin hormone that is key in the…

Read more

Triple Therapy for Chronic Obstructive Pulmonary Disease

Drugline Volume 345

From 1st June 2018, a triple combination inhaler was added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of chronic obstructive pulmonary disease (COPD). Trelegy® contains the corticosteroid fluticasone, the long-acting muscarinic antagonist…

Read more

Possible Risk of Birth Defects with Dolutegravir

Drugline Volume 344

The Therapeutic Goods Administration (TGA) has issued a safety advisory regarding the use of dolutegravir during pregnancy. Dolutegravir is an integrase inhibitor indicated for the treatment of HIV infection in combination with other antiretroviral agents. It can be…

Read more

Thrombolytic Therapy in Ischaemic Stroke

Drugline Volume 343

Alteplase and tenecteplase are tissue plasminogen activators that bind to fibrin within a thrombus to initiate fibrinolysis. Alteplase is approved in the treatment of myocardial infarction, pulmonary embolism, and acute ischaemic stroke; while tenecteplase…

Read more

Suspected Drug-Herb Interaction Raises INR

Drugline Volume 342

It is estimated that up to two-thirds of Australians use complementary and alternative medicines. While these agents are often thought to be safe, a recent case report highlights the potential for serious interactions with…

Read more

Daratumumab for Multiple Myeloma

Drugline Volume 341

Multiple myeloma is a cancer of the plasma cells of the bone marrow. While advances in therapy have significantly improved patient outcomes over the past decade, relapse is common which emphasises the importance of…

Read more
Load More

July 2018

April 2018

January 2018

December 2017

September 2017

Thunderstorm Asthma (Sep. 21 2017)

The Efficacy of Perampanel (Sep. 08 2017)

July 2017

June 2017

April 2017

March 2017

November 2016

September 2016

August 2016

April 2016

November 2015

Viekira Pak for Hepatitis C (Nov. 19 2015)

Micafungin (Nov. 05 2015)

October 2015

Dabigatran Antidote on the Horizon (Oct. 22 2015)

Akynzeo® (Oct. 08 2015)

September 2015

May 2015

April 2015

Victoza (liraglutide) (Apr. 23 2015)

Ultibro Breezhaler 100/50 (Apr. 09 2015)

March 2015

February 2015

December 2014

November 2014

October 2014

September 2014

World Pharmacist Day (Sep. 24 2014)

National Stroke Week (Sep. 11 2014)

August 2014

July 2014

Breo™ Ellipta® (Jul. 31 2014)

Use of Prolia® in Men (Jul. 17 2014)

Adcetris® (brentuximab vedotin) (Jul. 03 2014)

April 2014

March 2014

September 2013

August 2013

July 2013

June 2013

Riluzole for Motor Neurone Disease (Jun. 20 2013)

Mycamine (Jun. 06 2013)

May 2013

HPV Vaccine (May. 23 2013)

World Lupus Day (May. 09 2013)

December 2012

November 2012

August 2012